Mediation analysis was conducted, using TAGLN2 as exposure variables, metabolites as the mediator, and PAH as the outcome (Table S18, Supplemental Digital Content, https://links.lww.com/MD/Q396). This evidence concerns the gene TAGLN2 and pulmonary arterial hypertension.